Cook SD - Search Results

1

Serum levels of CXCL13 are elevated in active multiple sclerosis.

Festa ED, Hankiewicz K, Kim S, Skurnick J, Wolansky LJ, Cook SD, Cadavid D. Festa ED, et al. Among authors: cook sd. Mult Scler. 2009 Nov;15(11):1271-9. doi: 10.1177/1352458509107017. Epub 2009 Oct 5. Mult Scler. 2009. PMID: 19805441 Clinical Trial.

2

Clinical consequences of MRI activity in treated multiple sclerosis.

Cadavid D, Kim S, Peng B, Skurnick J, Younes M, Hill J, Wolansky LJ, Cook SD. Cadavid D, et al. Among authors: cook sd. Mult Scler. 2011 Sep;17(9):1113-21. doi: 10.1177/1352458511405375. Epub 2011 May 25. Mult Scler. 2011. PMID: 21613336 Clinical Trial.

3

Impact of inflammation on brain volume in multiple sclerosis.

Cheriyan J, Kim S, Wolansky LJ, Cook SD, Cadavid D. Cheriyan J, et al. Among authors: cook sd. Arch Neurol. 2012 Jan;69(1):82-8. doi: 10.1001/archneurol.2011.674. Arch Neurol. 2012. PMID: 22232347 Clinical Trial.

4

Cladribine in aggressive forms of multiple sclerosis.

Martinez-Rodriguez JE, Cadavid D, Wolansky LJ, Pliner L, Cook SD. Martinez-Rodriguez JE, et al. Among authors: cook sd. Eur J Neurol. 2007 Jun;14(6):686-9. doi: 10.1111/j.1468-1331.2007.01735.x. Eur J Neurol. 2007. PMID: 17539951

5

New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate.

Cadavid D, Cheriyan J, Skurnick J, Lincoln JA, Wolansky LJ, Cook SD. Cadavid D, et al. Among authors: cook sd. J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1337-43. doi: 10.1136/jnnp.2008.171090. Epub 2009 Aug 16. J Neurol Neurosurg Psychiatry. 2009. PMID: 19687024 Clinical Trial.

6

Aggressive central nervous system demyelination in an adolescent.

Solanky M, Van Engel D, Wolansky L, Cook SD. Solanky M, et al. Among authors: cook sd. Rev Neurol Dis. 2005 Winter;2(1):35-8. Rev Neurol Dis. 2005. PMID: 16400303 Review.

7

Could Epstein-Barr virus or canine distemper virus cause multiple sclerosis?

Lincoln JA, Hankiewicz K, Cook SD. Lincoln JA, et al. Among authors: cook sd. Neurol Clin. 2008 Aug;26(3):699-715, viii. doi: 10.1016/j.ncl.2008.03.004. Neurol Clin. 2008. PMID: 18657722 Review.

8

Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.

DeBevits JJ 4th, Munbodh R, Bageac D, Wu R, DiCamillo PA, Hu C, Wang L, Naismith RT, Karimeddini D, Dhib-Jalbut S, Redko S, Cook SD, Cadavid D, Wolansky L. DeBevits JJ 4th, et al. Among authors: cook sd. Invest Radiol. 2020 Oct;55(10):629-635. doi: 10.1097/RLI.0000000000000663. Invest Radiol. 2020. PMID: 32898355

9

MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.

Brown RA, Narayanan S, Stikov N, Cook S, Cadavid D, Wolansky L, Arnold DL. Brown RA, et al. Neurology. 2016 Aug 30;87(9):905-11. doi: 10.1212/WNL.0000000000003043. Epub 2016 Jul 29. Neurology. 2016. PMID: 27473139 Free PMC article. Clinical Trial.

10

MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.

Maranzano J, Rudko DA, Nakamura K, Cook S, Cadavid D, Wolansky L, Arnold DL, Narayanan S. Maranzano J, et al. Neurology. 2017 Aug 15;89(7):714-721. doi: 10.1212/WNL.0000000000004227. Epub 2017 Jul 19. Neurology. 2017. PMID: 28724581 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page